The Firm

Story and History

Since its founding in 1995, Faruqi & Faruqi has served as lead or co-lead counsel in numerous high-profile cases which ultimately provided significant recoveries to investors, consumers and employees.

Values and Philosophy

Value is a core part of our firm’s professional philosophy. We strive everyday to provide quality legal representation to our clients. This value driven approach is what you should expect from the law firm you select to handle your case. We demand that every member of our team deliver this value day in and day out.

Mission and Services

Faruqi & Faruqi, LLP is here to help our clients by providing them with a high degree of excellence in legal counsel.

Court Praises

Prior Case Disclaimer

The information contained in the Faruqi & Faruqi, LLP (“Faruqi & Faruqi” or the “firm”) Web site is provided for informational purposes only, and should not be construed as legal advice on any subject matter.

No recipients of content from this site, client or otherwise, should act or refrain from acting on the basis of any content included in the site without seeking the appropriate legal or professional advice on the particular facts and circumstances at issue from an attorney licensed in the recipient’s state. The content of this Web site contains general information and may not reflect current legal developments, verdicts or settlements. Faruqi & Faruqi expressly disclaims all liability in respect to actions taken or not taken based on any or all the contents of this site.

If you are interested in viewing information about Faruqi & Faruqi’s past results, please read and acknowledge the information below. The information in this section contains information about the firm’s past results, and may contain testimonials and statements regarding the firm’s quality. This information has not been reviewed or approved by the Florida Bar.

You should know the following:

1. The facts and circumstances of your case may differ from the matters in which results and testimonials have been provided;
2. All results of cases handled by the firm are not provided;
3. And the results provided are not necessarily representative of results obtained by the firm or of the experience of all clients or others with the firm.

Commitment to Diversity

Faruqi & Faruqi, LLP is committed to equal employment opportunities.  We are a firm founded by minorities and will not discriminate against employees or applicants for employment on any legally-recognized basis including, but not limited to: veteran status, uniform servicemember status, race, color, religion, sex, national origin, age, physical or mental disability, genetic information or any other protected class under the federal, state or local laws.  Faruqi & Faruqi, LLP is also committed to providing equal employment opportunities to qualified individuals with disabilities. Faruqi & Faruqi, LLP is certified as a Women’s Business Enterprise (WBE) through the Women’s Business Enterprise National Council (WBENC), the nation’s largest third party certifier of businesses owned and operated by women in the US.

We strive to create the best possible climate for maximum development and goal achievement for all employees. Our practice is to treat each employee as an individual.  We seek to develop a spirit of teamwork; individuals working together to attain a common goal.  In order to maintain an atmosphere where these goals can be accomplished, we provide a comfortable and progressive workplace.  Most importantly, we have a workplace where communication is open and problems can be discussed and resolved in a mutually respectful atmosphere.

Stay up-to-date

Latest Postings from Our Offices

Investigations
Cases
News
Blog
28 Oct 2025
Nidec Corporation
If you suffered significant losses in Nidec stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Nidec Corporation (“Nidec” or the “Company”) (OTC: NJDCY). STOCK DROP: On September 3, 2025, Nidec disclosed it had established a third-party committee to investigate suspicions of improper accounting. The Company further revealed its “investigations found multiple documents suggesting that . . . the Company and its group companies could have engaged in improper accounting with the involvement or knowledge of its or their management[.]” On this news, Nidec’s stock price fell $0.81, or 16.5%, to close at $4.11 per share on September 4, 2025, thereby injuring investors. Then, on September 26, 2025, Nidec disclosed further investigative findings of additional suspected inappropriate accounting practices, including “cases where the reported value for customs purposes was declared to be lower than the appropriate amount without legitimate reason.” The Company also revealed that it “received an audit report containing a disclaimer of opinion” from its auditor due to the “ongoing investigations by the third-party committee, other internal investigations, and other action[s].” On this news, Nidec’s stock price fell $0.29, or 6.6%, to close at $4.09 per share on September 26, 2025. Then, on October 23, 2025, Nidec published a press release announcing that it was withdrawing its year end forecast, and had decided not to pay a surplus dividend as “investigations by the Third Party Committee regarding suspected inappropriate accounting practices involving the Company and its group, as well as other internal investigations, are ongoing.” On this news, Nidec’s stock price fell $1.17, or 25.4%, to close at $3.43 on October 23, 2025. Finally, on October 27, 2025, the Tokyo Stock Exchange (“TSE”) designated Nidec under a Special Security alert in part because “TSE deems that the improvement of the internal management system of said listed company is highly necessary.” The alert noted that “[s]ince the initial issue was discovered, the scope of the investigation has continued to expand” and that “deficiencies have already been identified in the Company’s company-wide internal control systems (particularly in areas related to information and communication), as well as in the internal controls related to its accounting and financial closing processes.” On this news, Nidec’s stock price fell $0.80, or 20.3%, to close at $3.15 per share on October 27, 2025, thereby injuring investors further.  
James M. Wilson, Jr.
Robert W. Killorin
Take Action
27 Oct 2025
James Hardie Industries plc
Did You Lose Money in James Hardie Industries plc (NYSE:JHX) Stock? Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against James Hardie Industries plc (“James Hardie” or the “Company”) for alleged violations of federal securities laws. The firm reminds investors that they have until December 23, 2025 to seek appointment as lead plaintiff in the class action filed against the Company. The complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that James Hardie Industries plc misled investors about the strength of its key North America Fiber Cement segment between May 20 and August 18, 2025. Despite knowing by April and early May that distributors were destocking inventory, the company falsely claimed demand remained strong and that stock levels were “normal.” Lead Plaintiff Deadline: December 23, 2025 📞 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310) 💻 Or submit your information below to learn about your rights.
Robert W. Killorin
James M. Wilson, Jr.
Lead Plaintiff Deadline
54 Days
Take Action
18 Mar 2025
Caribou Biosciences, Inc.
On March 25, 2025, Honorable Vince Chhabria of the Northern District of California appointed Faruqi & Faruqi, LLP, as sole lead counsel in Saylor v. Caribou Biosciences, Inc. et al, Docket No. 3:24-cv-09413 (N.D. Cal. Dec 24, 2024). The Caribou Biosciences, Inc. class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) they had overstated CB-010’s safety, efficacy, and durability relative to approved autologous CAR-T cell therapies in treating patients with r/r B-NHL and/or LBCL, as well as CB-010’s overall clinical results and commercial prospects; (ii) Caribou was at significant risk of having insufficient cash, liquidity, and/or other capital to fund its current business operations, including preclinical research activities associated with the allogeneic CAR-NK platform; and (iii) all the foregoing was likely to have a significant negative impact on Caribou’s business and operations. For further inquiries regarding this matter, please contact James M. Wilson, Jr. at jwilson@faruqilaw.com or (212) 983-9330. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
James M. Wilson, Jr.
Robert W. Killorin
Read More
18 Mar 2025
Methode Electronics, Inc.
On February 3, 2025, Honorable Sara L. Ellis of the Northern District of Illinois appointed Faruqi & Faruqi, LLP, as sole lead counsel in Salem v. Methode Electronics, Inc. et al, Docket No. 1:24-cv-07696 (N.D. Ill. Aug 26, 2024). The Methode Electronics class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) Methode Electronics had lost highly skilled and experienced employees during the COVID-19 pandemic necessary to successfully complete Methode Electronics’ transition from its historic low mix, high volume production model to a high mix, low production model at its Monterrey facility; (ii) Methode Electronics’ attempts to replace its General Motors center console production with more diversified, specialized products for a wider array of vehicle manufacturers and OEMs, in particular in the electric vehicle (“EV”) space, had been plagued by production planning deficiencies, inventory shortages, vendor and supplier problems, and, ultimately, botched execution of Methode Electronics’ strategic plans; (iii) Methode Electronics’ manufacturing systems at its critical Monterrey facility suffered from a variety of logistical defects, such as improper system coding, shipping errors, erroneous delivery times, deficient quality control systems, and failures to timely and efficiently procure necessary raw materials; (iv) Methode Electronics had fallen substantially behind on the launch of new EV programs out of its Monterrey facility, preventing Methode Electronics from timely receiving revenue from new EV program awards; and (v) as a result, Methode Electronics was not on track to achieve the 2023 diluted earnings-per-share guidance or the 3-year 6% organic sales compound annual growth rate represented to investors and such estimates lacked a reasonable factual basis. For further inquiries regarding this matter, please contact James M. Wilson, Jr. at jwilson@faruqilaw.com or (212) 983-9330. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not.
James M. Wilson, Jr.
Robert W. Killorin
Read More
12 Sep 2025
Faruqi & Faruqi Beats Motion to Dismiss in Luminar Technologies Securities Litigation and Advances the Case to Discovery
Read More
4 Sep 2025
Faruqi & Faruqi Beats Motion to Dismiss in Sun-Maid Litigation
Read More
29 Oct 2025
New York City Council Passes Pay Data Reporting Law For Private Employers
Read More
24 Oct 2025
Alleged Pig Butchering Scam Kingpin Charged By DOJ; Agency Seizes A Record $15 Billion In Bitcoin
Read More

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771